BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 7846948)

  • 1. [The use of digitalis glycosides in atrial fibrillation].
    Knez A; Haberl R; Steinbeck G
    Z Kardiol; 1994; 83 Suppl 5():71-3. PubMed ID: 7846948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy of paroxysmal atrial fibrillation. Cardiac glycosides alone or combined with anti-arrhythmia agents?].
    Steinbeck G; Doliwa R; Bach P
    Dtsch Med Wochenschr; 1988 Dec; 113(48):1867-71. PubMed ID: 3143539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of oral propafenone versus quinidine in the treatment of recent onset atrial fibrillation: A randomized, prospective study.
    Kosior DA; Kochanowski J; Scisło P; Piatkowski R; Postuła M; Rabczenko D; Opolski G
    Cardiol J; 2009; 16(6):521-7. PubMed ID: 19950088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Conversion rate and prevention of recurrence of paroxysmal and sustained atrial fibrillation or atrial flutter with verapamil/quinidine].
    Trappe HJ; Pfitzner P
    Med Klin (Munich); 1996 Oct; 91(10):617-25. PubMed ID: 9019638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacologic restoration of sinus rhythm in atrial flutter and fibrillation].
    Vainer J; Smíd J; Cepeláková H; Hapala J; Topinka I; Topolcan O
    Vnitr Lek; 1989 Feb; 35(2):145-50. PubMed ID: 2711622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of intravenous amiodarone for the conversion of chronic atrial fibrillation. Amiodarone vs quinidine for conversion of atrial fibrillation.
    Kerin NZ; Faitel K; Naini M
    Arch Intern Med; 1996 Jan; 156(1):49-53. PubMed ID: 8526696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial fibrillation: rate control often better than rhythm control.
    Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: the effect of no treatment and high-dose amiodarone. A randomized, placebo-controlled study.
    Cotter G; Blatt A; Kaluski E; Metzkor-Cotter E; Koren M; Litinski I; Simantov R; Moshkovitz Y; Zaidenstein R; Peleg E; Vered Z; Golik A
    Eur Heart J; 1999 Dec; 20(24):1833-42. PubMed ID: 10581142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rate-control versus conversion strategy in postoperative atrial fibrillation: a prospective, randomized pilot study.
    Lee JK; Klein GJ; Krahn AD; Yee R; Zarnke K; Simpson C; Skanes A; Spindler B
    Am Heart J; 2000 Dec; 140(6):871-7. PubMed ID: 11099990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Amiodarone and verapamil/quinidine in treatment of patients with chronic atrial fibrillation].
    Zehender M; Meinertz T; Just H
    Z Kardiol; 1994; 83 Suppl 5():101-8. PubMed ID: 7846938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combination of quinidine and verapamil in auricular fibrillation].
    Sobrino JA; Maté I; Calvo L; Plaza I; Rico J; Moreno I; Mesa JM
    Rev Esp Cardiol; 1989 Apr; 42(4):262-6. PubMed ID: 2781120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation.
    Joseph AP; Ward MR
    Ann Emerg Med; 2000 Jul; 36(1):1-9. PubMed ID: 10874228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of sotalol with digoxin-quinidine for conversion of acute atrial fibrillation to sinus rhythm (the Sotalol-Digoxin-Quinidine Trial).
    Halinen MO; Huttunen M; Paakkinen S; Tarssanen L
    Am J Cardiol; 1995 Sep; 76(7):495-8. PubMed ID: 7653451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The efficacy of oral treatment with flecainide for paroxysmal atrial fibrillation: correlation with plasma concentration].
    Villani GQ; Rosi A; Piepoli M; Gandolfini A; Groppi F; Groppi M; Arruzzoli S; Dieci G; Gazzola U
    G Ital Cardiol; 1990 Jun; 20(6):564-8. PubMed ID: 2121574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation.
    Frick M; Darpö B; Ostergren J; Rosenqvist M
    Eur Heart J; 2000 Jul; 21(14):1177-85. PubMed ID: 10924301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical assessment of clonidine in the treatment of new-onset rapid atrial fibrillation: a prospective, randomized clinical trial.
    Simpson CS; Ghali WA; Sanfilippo AJ; Moritz S; Abdollah H
    Am Heart J; 2001 Aug; 142(2):E3. PubMed ID: 11479482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and effectiveness of oral quinidine in cardioversion of persistent atrial fibrillation.
    Kirpizidis C; Stavrati A; Geleris P; Boudoulas H
    J Cardiol; 2001 Dec; 38(6):351-4. PubMed ID: 11806093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhythm.
    Capucci A; Boriani G; Rubino I; Della Casa S; Sanguinetti M; Magnani B
    Int J Cardiol; 1994 Mar; 43(3):305-13. PubMed ID: 8181888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When should we discontinue antiarrhythmic therapy for atrial fibrillation after coronary artery bypass grafting? A prospective randomized study.
    Izhar U; Ad N; Rudis E; Milgalter E; Korach A; Viola N; Levi E; Asraff G; Merin G; Elami A
    J Thorac Cardiovasc Surg; 2005 Feb; 129(2):401-6. PubMed ID: 15678052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is newer better? Propafenone versus quinidine for conversion of atrial fibrillation.
    Daubert JP
    Cardiol J; 2009; 16(6):491-2. PubMed ID: 19950083
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 29.